A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/19 (2006.01) A61K 9/10 (2006.01) A61K 9/51 (2006.01) A61K 47/42 (2006.01)
Patent
CA 2125281
A medicament for immediately treating painful, inflammatory and/or febrile diseases contains as active substance ibuprofen as a racemate, as a racemic mixture with its enantiomers, as a pseudoracemate (mixtures of equal parts of S- and R-ibuprofen) or as a mixture of different parts of S- and R-ibuprofen in a range between pure S- and pure R-ibuprofen in the form of a pharmaceutically applicable nanosol and satisfies all requirements of an immediate-effect pharmaceutical form. It can in addition be combined with a slow-release, medicament that contains as active substance ibuprofen as a racemic compound, as a pseudoracemate (mixtures of equal parts of S- and R ibuprofen) or as a mixture of different parts of S- and R-ibuprofen in a range between pure S- and pure R-ibuprofen, in the form of a pharmaceutically applicable, gelatine-based nanosol.
Médicament pour le traitement immédiat des affections douloureuses, inflammatoires et/ou fébriles contenant comme principe actif l'ibuprofène comme racémate, comme composé racémique avec ses énantiomères, comme pseudoracémate (mélanges de parts égales de S- et R-ibuprofène) ou comme mélange de parts différentes de S- et R- ibuprofène dans une plage entre le S-ibuprofène pur et le R-ibuprofène pur sous forme de nanosol pharmaceutiquement applicable et satisfait à toutes les conditions d'une forme pharmaceutique à action immédiate. De plus, il peut être associé à un médicament retard qui contient de l'ibuprofène comme principe actif comme composé racémique, comme pseudoracémate (mélanges de parts égales de S- et de R-ibuprofène) ou un mélange de parts différentes de S- et R-ibuprofène dans une plage entre le S-ibuprofène pur et le R-ibuprofène pur, sous forme de nanosol à base de gélatine pharmaceutiquement applicable.
Lukas Helmut
Schick Ursula
Schuster Otto
Wunderlich Jens-Christian
Alfatec-Pharma Gmbh
Dennison Associates
Paz Arzneimittelentwicklungsgesellschaft Mbh
LandOfFree
Immediate-effect ibuprofen-containing medicament and its use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immediate-effect ibuprofen-containing medicament and its use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immediate-effect ibuprofen-containing medicament and its use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1827328